LUOXIN PHARMACEUTICAL Trademark

Trademark Overview


On Thursday, July 18, 2019, a trademark application was filed for LUOXIN PHARMACEUTICAL with the United States Patent and Trademark Office. The USPTO has given the LUOXIN PHARMACEUTICAL trademark a serial number of 79267215. The federal status of this trademark filing is REGISTERED as of Tuesday, October 27, 2020. This trademark is owned by SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD.. The LUOXIN PHARMACEUTICAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for peripheral nervous system; medicinal tea; Chinese medicine nostrum in the nature of natural remedy preparations for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, cerebral ischemia, prostate disease, infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; medicinal herbs; biochemical medicines for the treatment of pneumonia, urinary tract infection, gynecological infections, skin and skin structure infections, meningitis, septicemia, cancer, ...
luoxin pharmaceutical

General Information


Serial Number79267215
Word MarkLUOXIN PHARMACEUTICAL
Filing DateThursday, July 18, 2019
Status700 - REGISTERED
Status DateTuesday, October 27, 2020
Registration Number6181988
Registration DateTuesday, October 27, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 11, 2020

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined TextTHE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "YAO YE" AND THE WORD "PHARMACEUTICAL"
Description of MarkThe mark consists of a design comprising two intersecting curved bands with horizontal stripes that form a Y-shaped figure. Above this design is an eight-pointed star. Two non-Latin characters appear, respectively, on the left and right of the bottom of the design. To the right of the foregoing elements are four non-Latin characters in horizontal arrangement above the wording "LUOXIN PHARMACEUTICAL" in stylized lettering.
Goods and ServicesPharmaceutical preparations for use in chemotherapy; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for peripheral nervous system; medicinal tea; Chinese medicine nostrum in the nature of natural remedy preparations for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, cerebral ischemia, prostate disease, infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; medicinal herbs; biochemical medicines for the treatment of pneumonia, urinary tract infection, gynecological infections, skin and skin structure infections, meningitis, septicemia, cancer, diabetes, prostate disease, infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; biochemical drugs for treatment of gastrointestinal diseases; antiseptics; dental lacquer; diapers for pets; medicinal alcohol; medicinal oils; amino acids for medical purposes
Pseudo MarkLUO XIN PHARMACEUTICAL
Transliteration StatementThe transliteration of the non-Latin characters in the mark is: The two non-Latin characters on the left of the mark from left to right transliterate to "LUO""XIN", where "LUO" is a surname and "XIN" means "GLAD" in English. The four non-Latin characters on the right of the mark from left to right transliterate to "LUO" "XIN" "YAO" "YE" where "LUO" is a surname, "XIN" means "GLAD" and "YAO YE" means "PHARMACEUTICAL" in English.
Translation of Words in MarkThe English translation of the word "LUOXIN" in the mark is comprised of the surname "LUO" and the term "XIN", which means "GLAD" in English.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressShandong 276017
CN

Party NameSHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressShandong 276017
CN

Party NameSHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShandong 276017
CN

Trademark Events


Event DateEvent Description
Sunday, March 7, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, February 9, 2021GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, February 9, 2021GENERIC MADRID TRANSACTION CREATED
Wednesday, January 27, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 27, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, August 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2020PUBLISHED FOR OPPOSITION
Friday, August 7, 2020NOTIFICATION PROCESSED BY IB
Wednesday, July 22, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 22, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 8, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, July 8, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 8, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, July 8, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 27, 2020REFUSAL PROCESSED BY IB
Thursday, February 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020NON-FINAL ACTION WRITTEN
Wednesday, January 22, 2020ASSIGNED TO EXAMINER
Thursday, December 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 26, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 23, 2019ASSIGNED TO LIE
Saturday, December 14, 2019REFUSAL PROCESSED BY IB
Sunday, December 8, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 27, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, November 27, 2019REFUSAL PROCESSED BY MPU
Tuesday, November 5, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 4, 2019NON-FINAL ACTION WRITTEN
Friday, October 4, 2019ASSIGNED TO EXAMINER
Tuesday, September 24, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, September 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 17, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 12, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB